Both podocyte‐specific Sirt1 overexpression and Sirt1 agonist treatment could attenuate diabetes‐induced podocyte apoptosis and effectively alleviate the progression of diabetic kidney disease in diabetic mice.12 This evidence concerns the gene SIRT1 and diabetes mellitus.